TickerFacts.

LENSAR, Inc. (LNSR): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$27.12M
Year ended 2025-12-31
$29.13M
Trailing 12 months to 2026-06-30
+10.8%
3-year compound annual growth
+14.0%
5-year compound annual growth
2019-12-31: $13.23M2020-12-31: $14.07M2021-12-31: $17.83M2022-12-31: $19.95M2023-12-31: $21.11M2024-12-31: $25.85M2025-12-31: $27.12M$27.12M
2019-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$27.12M+4.9%2026-03-31, From 2025-01-01
2024-12-31$25.85M+22.5%2026-03-31, From 2024-01-01
2023-12-31$21.11M+5.8%2025-02-27, From 2023-01-01
2022-12-31$19.95M+11.9%2024-03-04, From 2022-01-01
2021-12-31$17.83M+26.7%2023-03-16, From 2021-01-01
2020-12-31$14.07M+6.4%2022-03-03, From 2020-01-01
2019-12-31$13.23Mn/a2021-03-12, From 2019-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
LENSAR, Inc. (LNSR)2025-12-31$27.12M+4.9%
CVRx, Inc. (CVRX)2025-12-31$48.34M+12.5%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$19.16M-42.5%
Apyx Medical Corp (APYX)2025-12-31$33.04M+12.5%
Carlsmed, Inc. (CARL)2025-12-31$38.04M+89.7%
AVITA Medical, Inc. (RCEL)2025-12-31$58.82M+6.6%
Shoulder Innovations, Inc. (SI)2025-12-31$36.20M+48.7%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$38.19M+50.8%
Sight Sciences, Inc. (SGHT)2025-12-31$66.67M-2.4%

Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗